Authors
Latest:
Community Engagement Is Crucial When Taking Action Against Climate ChangeBeth A. Malow, MD, MS, FAAN, said that pharmacists and health care professionals are at the frontlines of collaborating and raising awareness of climate change’s impacts.
Latest:
Asembia AXS25: Strategic Partnerships Driving Pharmaceutical InnovationSpecialty distributors provide strategic partnerships that enhance pharmaceutical manufacturers' ability to bring innovative medicines to market.
Latest:
Counsel Patients Who Have Questions About Maternal RSV ImmunizationsRSVpreF is currently the only FDA-approved RSV vaccine for pregnant individuals.
Latest:
Potential for Precision: Exploring Targeted Therapies in mCRC CarePanelists discuss how the importance of having pharmacists embedded in oncology clinics has transformed metastatic colorectal cancer care by enabling real-time decision-making and dose adjustments, while highlighting that these are exciting times with multiple new oral treatment options that patients often prefer over infusions, though managing adherence and side effects remains challenging, and emphasizing that current targeted therapy opportunities include rare but actionable NTRK fusions, HER2 amplifications (3% of cases with multiple treatment options), and KRAS G12C mutations (3% of cases), with future promise in pan-RAS inhibitors, expanded immunotherapy beyond MSI-high tumors, and combination therapies, though dermatologic toxicity from targeted agents like RAS inhibitors will likely be the rate-limiting factor requiring better assessment tools and multidisciplinary management including dermatology support.
Latest:
Gene Therapies Hold Promise for Neuromuscular and Other Rare DiseasesChallenges remain, however, to therapy development for a limited patient population.
Latest:
Building a Path to Cure for Patients With NSCLC Who Have Never SmokedHow patients acquire NSCLC plays a role in health outcomes, with never-smoker patients having genetically different disease than the same disease in smokers.
Latest:
5 Ways Pharmacies Can Use Texting to Boost Patient EngagementTexting with patients can help to improve pharmacy processes while creating better user experiences.
Latest:
New Treatment Options Are on the Horizon for β-ThalassemiaGene therapies in late-stage development may soon provide hope for a cure.
Latest:
Helping Pharmacists Excel in the ‘New Normal’With more work and less staff, we need to examine how we can better support pharmacists in the new normal brought on by COVID-19.
Latest:
Securing the Supply Chain: The DSCSA and the New Importation Policy in FloridaIn January 2024, Florida became the only state to allow the importation of medications for public use.
Latest:
Considerations for Environmentally Conscious Pharmacy StudentsEnvironmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Latest:
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood CancerAdvances, challenges, and promising innovations emerge.
Latest:
The Role of Medicinal Plants in Modern PharmacyResearchers are working to solve consistency and ecological and ethical concerns in pharmaceutical formulations
Latest:
Recognize the Value of Health Care VolunteersThe health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
Latest:
Evaluation of a Pharmacy-Delivered Oncofertility InterventionThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Interprofessional Education in Medical School Creates a Collaborative EnvironmentAdaptability, teamwork, and a culture of lifetime learning are required virtues in our rapidly evolving medical landscape.
Latest:
Navigating the Rapid Growth of Specialty Drugs: Opportunities, Challenges, and the Path AheadHigh-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.
Latest:
The Future of Cancer Drug Development: Advancements, Challenges, and the Transformative Role of AIAI is revolutionizing oncology drug development, enhancing therapeutic identification and reducing approval times, but use of this tool must be carefully implemented to mitigate risks and ensure regulatory compliance.
Latest:
It Is Time to Consider Alternatives to Discipline ProgramsProfessional assistance programs provide pathway for health care professionals to return to practice following treatment for substance use disorder.
Latest:
What Drug Rates Are Reported in Price Transparency Data?It is valuable for pharmacists to understand exactly how price transparency data are sourced, what information can be found, antitrust concerns, and implications for the pharmaceutical industry.
Latest:
Understanding Pharmacogenomics Is Essential for Personalized CarePharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.
Latest:
Bacteroidetes: The Jekyll and Hyde of the Human Gut MicrobiomeThe relative abundance of gram-negative Bacteroidetes to other phyla, such as gram-positive Firmicutes, is essential to maintain biodiversity and human gut health.
Latest:
Therapies Under Investigation for Waldenström MacroglobulinemiaThe exciting therapies in the pipeline that are thought to target novel mechanisms in Waldenström macroglobulinemia.
Latest:
Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical ConsiderationsThis article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Latest:
Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating FactorThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
ASCO 2025: Real-World Data Support Rechallenging Trastuzumab Deruxtecan After ILDHope Rugo, MD, discusses a multi-institutional real-world analysis showing that rechallenging trastuzumab deruxtecan after grade 1 interstitial lung disease (ILD) is generally safe and effective.
Latest:
Insights on the UK's MHRA International Recognition ProcedureThe UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Latest:
Expert: Pharmacists Play Critical Role in Vaccination, Public Health Amid Ongoing Viral RisksPharmacists have been central to vaccine distribution since the COVID-19 pandemic, and as viruses spread, they must continue urging patients to stay updated on vaccinations to prevent severe illness and reduce hospitalizations.
